Iyke Emeto

Associate Professor Theophilus I. Emeto, PhD James Cook University, MBiostatistics The University of Queensland, MSc (Distinction) University of Nottingham, CStat, FIMC, CMC, CMS.

Theophilus (Iyke) Emeto is a Chartered Biostatistician registered with the Royal Statistical Society, and Section Head, Public Health and Tropical Medicine Research Methods Group (PHTMRMG). He is a key member of the World Health Organization Collaborating Centre for Vector-borne and Neglected Tropical Diseases, and a Senior Collaborator on the Global Burden of Disease Network. His work has been cited in more than 180 policy documents, (SAGE Policy Profiles) including by the WHO, OECD, CGIAR, World Bank, PAHO, Gates Foundation, and the Council of the European Union, and he appears in the Stanford/Elsevier list of the world's top 2% of scientists (2025).  

Iyke's academic path has been, fittingly for a biostatistician, admirably non-linear. He began with a BSc (Hons) in Medical Physiology at the University of Calabar, where he defined prediction formulae for lung function parameters in Nigerian children aged 6 to 16.  A Distinction in MSc Immunology and Allergy followed at the University of Nottingham, where he investigated the effect of the house dust mite allergen Der p 1 on T-regulatory and Th17 cells in allergic asthma. He then completed an MBiostatistics through the The University of Queensland, and the Biostatistics Collaboration of Australia, examining how best to analyse longitudinal clinical trials plagued by incomplete outcome data, a problem he has been circling, productively, ever since. His PhD at James Cook University (2013) turned to the weakening human aorta, probing the mechanisms behind abdominal aortic aneurysm and the prospects for a drug-based therapy. Along the way he worked as a Research Scientist with Oxford BioMedica UK, analysing immune responses to the therapeutic cancer vaccine TroVax® (MVA-5T4), and as a Research Assistant at the Tenovus Research Laboratories, University of Southampton, UK, on combined immuno- and chemotherapy for neuroblastoma.

Iyke leads PHTMRMG in coordinating and teaching undergraduate research methods (HS2402, HS2405/3401) and postgraduate subjects (TM5506, TM5515, TM5516, TM5527, TM5549, TM5310). The Group provides research support to staff and students across the Academy and to clinicians in the Far North Hospital and Health Services, including the Townsville University Hospital, spanning project design, ethics, grants, statistical analysis and interpretation, and the long road to publication. He believes good research is done slowly but rigorously, and that our task is to equip people to do it, not to improve life for some or for one, but for all. He would, by his own admission, rather be the flat bass two in a choir's rendition of Fauré's Requiem in D minor than the lead of a boy band, a preference that tells you most of what you need to know about how he works. His analytical interests are broad: the detection, diagnosis, monitoring and management of chronic inflammatory diseases, haematological and oncological malignancies, and the health of deprived communities. Most recently he has returned to an old preoccupation, how to handle truncation of primary outcome data in longitudinal studies.

He is always happy to hear from prospective PhD and masters students.

Iyke is active in research capacity building across the Asia-Pacific, serving as a mentor within the JCU/UPNG Twinning Project and Tropical Partners, supporting colleagues in Fiji, Papua New Guinea, and the Solomon Islands. Nationally, he collaborates with the University of Queensland, Charles Sturt University, Federation University, Edith Cowan University, and the Universities of Melbourne, Sydney, and Central Queensland. Internationally, his partners include the University of Cambridge (UK), the Institute of Epidemiology (Germany), the University of Houston College of Pharmacy and the Medical University of South Carolina (USA), the University of Auckland and Massey University (NZ), Landmark University and the University of Lagos (Nigeria), and the University of Papua New Guinea.

Iyke has been an Equity Contact Officer (ECO) at JCU since it's inception. He serves as Specialty Chief Editor, Frontiers in Epidemiology, Biostatistical Editor, Therapeutic Advances in Infectious Disease, and Guest Associate Editor Frontiers in Cardiovascular Medicine (Atherosclerosis & Vascular Medicine Section), and Frontiers in Public Health , alongside guest editing for the International Journal of Environmental Research and Public Health. He reviews for several journals.

Program Overview

My research leadership focuses on advancing biostatistical methodology and epidemiological frameworks to enhance the reliability, inclusivity, and translational reach of health-system evidence. Applied primarily within tropical, regional, rural, and remote (RRR), and Asia-Pacific and African settings, my work centres on three strategic pillars:

Population Health Surveillance: Developing robust statistical models for longitudinal surveillance and epidemiological risk prediction in underserved populations.

Intervention Evaluation: Applying advanced quantitative designs to evaluate clinical trials, health services, and public health interventions.

Quantitative Capability Building: Strengthening research capacity across multidisciplinary teams through rigorous study design, data governance, and reproducible analytical workflows.

Strategic Disease Specialisations & Methodological Domains

Underserved populations & Chronic Disease Epidemiology

Cardiovascular Disease & Inequities: Quantifying incidence, risk trajectories, and health outcomes among underserved populations.

Chronic Inflammatory & Oncological Conditions: Applying survival analysis, multilevel modelling, and longitudinal methods to investigate complex disease pathways in haematological, oncological, and chronic inflammatory conditions.

Tropical Medicine & Health Equity

Neglected Tropical & Vector-Borne Diseases: Modelling transmission dynamics, risk factors, and intervention efficacy for NTDs and vector-borne infections across tropical and regional environments.

Social & Environmental Determinants: Measuring the systemic impact of socioeconomic disadvantage, geographic isolation, and health determinants in RRR communities to inform targeted policy and resource allocation.

Advanced Biostatistics & Statistical Modelling

Core & Advanced Theory: Delivering engaging coursework in foundational probability, hypothesis testing, ANOVA, and generalised linear models across undergraduate, postgraduate, and HDR programs.

Complex Data Analytics: Developing specialised training in survival analysis, longitudinal and multilevel modelling, Bayesian inference, and modern predictive analytics.

Reproducible Computing: Training students in robust, code-based analytical workflows using modern statistical platforms.

Methodological Rigour & Research Integrity

Study Design & Architecture: Teaching the principles of observational and experimental study designs (e.g., RCTs, cohort, and case-control studies) tailored to health and biomedical contexts.

Validity & Appraisal: Guiding students to identify and control bias, handle confounding, and critically appraise quantitative literature.

Data Governance & Open Science: Promoting best practices in data management, research ethics, and reproducible analytical pipelines.

Research Capacity Building & Mentorship

HDR & Early-Career Supervision: Mentoring postgraduate researchers in study design, advanced analytics, and writing high-impact journal publications.

Grant & Protocol Strategy: Facilitating practical workshops on statistical analysis plans, power calculations, and methodological frameworks for competitive funding applications.

Translational Communication: Teaching researchers to translate complex statistical outputs into clear, actionable evidence for academic, clinical, and policy audiences.